click & collect
Collect your order in-store R35 or FREE for orders over R350.
Ulsanic
Suspension 250ml
Ulsanic Suspension 250ml is specially formulated to treat and relieve the symptoms of peptic ulcers, chronic gastritis, reflux oesophagitis and hyperacidity.
In Stock
Store pick-up
Collect your order in-store R35 or FREE for orders over R350.
Standard Delivery
Door-to-door courier nationwide R80 or FREE for orders over R650.
Find in-store
See if we have this item in your closest store
R463.20
eB: 4640
Delivered in 1 - 6 working days.
In Stock
Standard delivery
Door-to-door courier nationwide R80 or FREE for orders over R650.
More Information
Detailed information
Description:
ULSANIC Suspension Syrup Orange Flavour 250ml
Detailed Description:
Gastric ulcer, duodenal ulcer, chronic gastritis and reflux oesophagitis. ULSANIC produces relief of subjective symptoms of peptic ulceration e.g. epigastric pain, hyperchlorhydria, vomiting. Maintenance treatment after successful endoscopically proven, recently healed duodenal ulcer.
Pack size:
1
Quantity in pack:
250ml
Marketing description:
To treat and relieve symptoms of Peptic Ulcers, Chronic Gastritis, Reflux Oesophogitis, Hyperacidity
Brand:
Ulsanic
Package type:
Pack
How to use
Usage instructions:
Take 5ml of suspension three or four times a day between meals and at bedtime. 10 ml of suspension twice daily (morning and evening) has been shown to be effective for the treatment of duodenal ulcer.
How to use:
Adult: The usual adult dosage is one tablet or one effervescent tablet or 5 ml (one medicine measure) of suspension three or four times a day between meals and at bedtime
Storage instructions:
Store in a dry place at or below 25 °C. Protect from light.
Warnings:
ULSANIC should be administered with caution in patients with renal impairment or on dialysis, due to the possibility of increased aluminium absorption. In patients with renal failure, absorption of aluminium may cause adverse effects. Aluminium accumulation and toxicity (aluminium osteodystrophy, osteomalacia, encephalopathy) have been described in patients with renal impairment. Blood levels of aluminium, phosphate, calcium, alkaline phosphatase, should be periodically measured in these patients.